CTSA Funding Information
The CTSA program provides critical resources and support needed to strengthen the entire spectrum of our nation's clinical and translational research enterprise. Funded institutions provide core resources, essential mentoring and training, and opportunities to develop innovative approaches and technologies designed to re-engineer existing capabilities. Program support also fosters collaborations to improve the quality, safety, efficiency and speed of clinical and translational research.
Currently, NCATS is soliciting applications for the following funding opportunity:
- RFA-TR-14-009: Clinical and Translational Science Awards (U54)
This funding announcement includes application instructions, eligibility information and details about the evolution of the program.
Please note that NOT-TR-14-012: Notice of Change in the Application Due Date in RFA-TR-14-009 "Clinical and Translational Science Award (U54)" extends the application due date for RFA-TR-14-009 until Jan. 15, 2015, and updates the other key dates accordingly.
View all of NCATS’ current funding opportunities.
Research Performance Progress Reports
NIH Guide notice, NOT-OD-15-014, requires that all grant progress reports for the CTSA UL1, KL2 and TL1 mechanisms be submitted electronically using the Research Performance Progress Report (RPPR) format. Please visit the NIH RPPR website for an overview and technical assistance for preparing and submitting reports. NCATS also has prepared specific guidance for CTSAs and frequently asked questions. Download the Oct. 23, 2014, webinar archive on this topic or read the transcript.
Notice of Proposed Rulemaking
HHS and NIH take steps to enhance transparency of clinical trial results.
Current Funding Opportunity
NCATS held a technical assistance webinar on Sept. 17, 2014, to review RFA-TR-14-009.
Download the webinar video.
Right click and save target/file